This inventor holds 2 USPTO granted patents. Top assignees: Sloan-Kettering Institute for Cancer Research, University of Rochester. Active years: 1996-1997.
Company Filing History:
2 out of 518 
2 out of 994 
Years Active: 1996-1997
Title: The Innovative Contributions of J Ellis Bell
Introduction
J Ellis Bell, a distinguished inventor based in Saint Peters, Minnesota, has made significant contributions to the field of pharmaceuticals. With two patents to his name, his work primarily focuses on the development of novel compounds that can play a crucial role in treating serious medical conditions.
Latest Patents
Bell's latest patents include groundbreaking inventions that provide valuable pharmaceutical compositions. The first patent, titled "Analogues of Adenosine 5'Diphosphate and Pharmaceutical Compositions," describes a compound with specific structural features designed to treat mammalian disorders associated with NAD-dependent enzymes. The detailed structure includes various hydrogen and fluorine substitutes, allowing for diverse applications in medicine.
The second patent, "C-Nucleoside Isosters of Analogs Thereof and Pharmaceutical Compositions," similarly outlines a compound with intricate structural properties aimed at facilitating therapeutic methods for similar disorders. Both inventions not only include the structures but also the methods for preparing these compounds, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, J Ellis Bell has collaborated with prestigious institutions such as the Sloan-Kettering Institute for Cancer Research and the University of Rochester. His contributions have pushed boundaries in pharmaceutical research, particularly in compounds that target enzyme-linked diseases.
Collaborations
In his professional journey, Bell has worked closely with notable individuals like Kyoichi A Watanabe and Krzystof W Pankiewicz. Their collaborations have likely fostered innovative solutions to complex medical challenges, emphasizing the importance of teamwork in research and development.
Conclusion
J Ellis Bell's inventive spirit and dedication to pharmaceutical innovation have led to significant advancements in the field. His patents not only reflect his expertise but also promise to contribute positively to medical treatments for enzyme-related disorders. As he continues his work, the potential for further advancements remains bright, ensuring that his legacy in the world of inventions will endure.